Speakers

Paul Alloway

Vice President & Head of Legal at Foghorn Therapeutics (Cambridge, MA)

Realities and Illusions of Patent Strength: Analyzing Legal Developments Impacting IP Validity

November 29, 2018 8:45 am

Greg Bell

Group Vice President and Life Sciences Practice Leader at Charles River Associates (Boston, MA)

The Best Things in Life are NOT Free: Assessing the Intricacies of Deal-Related IP Valuation

November 30, 2018 9:00 am

Matt Blischak

Vice President, Intellectual Property Counsel at Roivant Sciences, Inc. (New York, NY)

Be in the Room Where it Happens: Knowing how to Effectively and Successfully Communicate with the IP Due Diligence Team

November 29, 2018 3:45 pm

Nicholas Boivin

Chief Intellectual Property Counsel at Forma Therapeutics (Watertown, MA)

Data Rooms with a View: Eyeing E-room Strategies for IP Due Diligence Projects

November 30, 2018 11:15 am

Ralph W. Carmichael

Chairman & Chief Executive Officer at BŌNWRx Ltd. (Lansing, MI)

Money Talks — Venture Capitalist Spotlight with:

November 30, 2018 8:15 am

Catherine Eckenswiller

Legal Counsel – Intellectual Property & Agreements at VBI Vaccines Inc. (Ottawa, CA)

Will the Real Inventors Please Stand Up: Ensuring Proper Inventorship in an IP Due Diligence Analysis

November 29, 2018 9:45 am

Jeffrey J. Ellison, Ph.D.

Partner at Clark + Elbing LLP (Boston, MA)

Data Rooms with a View: Eyeing E-room Strategies for IP Due Diligence Projects

November 30, 2018 11:15 am

Alysia A. Finnegan, Ph.D., Esq.

Counsel, Intellectual Property Group at Merck & Co. Inc. (Rahway, NJ)

Be in the Room Where it Happens: Knowing how to Effectively and Successfully Communicate with the IP Due Diligence Team

November 29, 2018 3:45 pm

Geoffrey Taylor Gibbs

Deputy General Counsel, Business, Finance and Innovation at University of California, Office of the President (Oakland, CA)

The Best Things in Life are NOT Free: Assessing the Intricacies of Deal-Related IP Valuation

November 30, 2018 9:00 am

Kimya Harris, Ph.D.

Vice President, Head of Intellectual Property and Legal Affairs at KSQ Therapeutics (Cambridge, MA)

Will the Real Inventors Please Stand Up: Ensuring Proper Inventorship in an IP Due Diligence Analysis

November 29, 2018 9:45 am

Drew Holmes, Ph.D.

Senior Patent Attorney at Novartis Pharmaceuticals Corp. (East Hanover, NJ)

Pointing the Finger: When Defective IP Due Diligence Wrecks the Deal

November 30, 2018 12:00 pm

Thomas L. Irving

Partner at Finnegan Henderson Farabow Garrett & Dunner LLP (Washington, DC)

Be in the Room Where it Happens: Knowing how to Effectively and Successfully Communicate with the IP Due Diligence Team

November 29, 2018 3:45 pm

Brenda Jarrell, Ph.D.

Co-Chair of Intellectual Property and Life Sciences at Choate, Hall & Stewart LLP (Boston, MA)

The Best Things in Life are NOT Free: Assessing the Intricacies of Deal-Related IP Valuation

November 30, 2018 9:00 am

Philip Johnson

Former Senior VP for IP Policy & Strategy at Johnson & Johnson (New Brunswick, NJ)

Fireside Chat on Global Factors Influencing IP Due Diligence with:

November 30, 2018 10:30 am

Mark D. Kafka

Associate Director, Assistant General Counsel at Genentech, Inc. (South San Francisco, CA)

Sizing up the Competition: Conducting Thorough and Cost-Efficient Freedom to Operate Analyses

November 29, 2018 1:15 pm

Lacy Kolo, Ph.D.

Director, Tech and IP Advisory at Houlihan Lokey (McLean, VA)

Decision Drivers — The Private Equity Perspective with:

November 29, 2018 2:30 pm

John Krayacich

Vice-President & Head, Business Development & Licensing at Novartis Pharmaceuticals Corp. (East Hanover, NJ)

Examining the Due Diligence Inner Sanctum

November 29, 2018 11:15 am

Forrester J. Liddle Ph.D., J.D.

Director of Intellectual Property at Jounce Therapeutics (Cambridge, MA)

The Best Things in Life are NOT Free: Assessing the Intricacies of Deal-Related IP Valuation

November 30, 2018 9:00 am

Jane M. Love, Ph.D.

Partner at Gibson, Dunn & Crutcher LLP (New York, NY)

Pointing the Finger: When Defective IP Due Diligence Wrecks the Deal

November 30, 2018 12:00 pm

Donna Meuth

Associate General Counsel – Intellectual Property at Eisai Inc. (Andover, MA)

Realities and Illusions of Patent Strength: Analyzing Legal Developments Impacting IP Validity

November 29, 2018 8:45 am

Mercedes K. Meyer, Ph.D., J.D.

Partner at Drinker Biddle & Reath LLP (Washington, DC)

Be in the Room Where it Happens: Knowing how to Effectively and Successfully Communicate with the IP Due Diligence Team

November 29, 2018 3:45 pm

The Honorable Paul R. Michel (Ret.)

Former Chief Judge at United States Court of Appeals for the Federal Circuit (Alexandria, VA)

Fireside Chat on Global Factors Influencing IP Due Diligence with:

November 30, 2018 10:30 am

Ahmed Mousa, J.D.

Vice President, Licensing, IP & Legal Affairs at Pieris Pharmaceuticals Inc. (Boston, MA)

Sizing up the Competition: Conducting Thorough and Cost-Efficient Freedom to Operate Analyses

November 29, 2018 1:15 pm

Ryan Murphey

Counsel at Ropes & Gray LLP (New York, NY)

Will the Real Inventors Please Stand Up: Ensuring Proper Inventorship in an IP Due Diligence Analysis

November 29, 2018 9:45 am

Melanie R. Rupert

Partner, Life Sciences IP Litigation Global Co-Chair, Talent Development at Paul Hastings (New York, NY)

Realities and Illusions of Patent Strength: Analyzing Legal Developments Impacting IP Validity

November 29, 2018 8:45 am

Alicia A. Russo

Partner at Venable Fitzpatrick

Sizing up the Competition: Conducting Thorough and Cost-Efficient Freedom to Operate Analyses

November 29, 2018 1:15 pm

Jennifer Zarutskie Sieczkiewicz

Vice President, Chief Intellectual Property Counsel at Wave Life Sciences (Cambridge, MA)

Be in the Room Where it Happens: Knowing how to Effectively and Successfully Communicate with the IP Due Diligence Team

November 29, 2018 3:45 pm

Len Smith

Principal Counsel and Co-Founder at Transformative Legal (Scottsdale, AZ)

Be in the Room Where it Happens: Knowing how to Effectively and Successfully Communicate with the IP Due Diligence Team

November 29, 2018 3:45 pm

Gary J. Speier

Shareholder at Carlson Caspers Vandenburgh Lindquist & Schuman, PA (Minneapolis, MN)

Be in the Room Where it Happens: Knowing how to Effectively and Successfully Communicate with the IP Due Diligence Team

November 29, 2018 3:45 pm

Ha Kung Wong

Due Diligence Head CM and NS at Venable Fitzpatrick

Be in the Room Where it Happens: Knowing how to Effectively and Successfully Communicate with the IP Due Diligence Team

November 29, 2018 3:45 pm

Frederick K. Young, Ph.D.

Due Diligence Head CM and NS at Novartis Pharmaceuticals Corp. (East Hanover, NJ)

Examining the Due Diligence Inner Sanctum

November 29, 2018 11:15 am